Decision on flu vaccine looms
Wall Street Journal, May 7, 2009
The Obama administration is weeks away from a critical decision on whether to trigger mass production of swine-flu vaccine, which could affect the bottom lines of big vaccine makers as well as public health.
Besides determining whether a vaccine would be effective and safe, government officials and private laboratories will need to answer whether it makes sense to order hundreds of millions of doses and organize a mass vaccination campaign for a virus that, so far, isn't widespread and doesn't seem particularly lethal.
Most Viewed
Most Emailed
- $6.4B Henry Ford, Beaumont Merger Failed on Cultural Hurdles
- How Chargemaster Data May Affect Hospital Revenue
- Primary Care Docs Average More Hospital Revenue Than Specialists
- House Lawmakers Grill CMS Over Health Exchange Navigators
- Fortunately, Angelina Jolie Isn't On Medicare
- ED Physicians Key to Half of Hospital Admissions
- Don't Let Nurses Sink Your Bottom Line
- Insurer's App Aims to Lower Healthcare Costs, Securely
- 69% of Employers Plan to Offer Healthcare Coverage After 2014
- Uncompensated Care Faces a Double Hit in Some States
